top of page

We Provide

Peptide Pharmaceuticals biosimilar

Obesity and Diabetes





Short Bowel Syndrome


Core Technology


High Yield Protein Expression & Refolding

HYPER is a technology that integrates high efficiency fermentation and purification processes, producing a large amount of peptides compared to other fusion partners and maximizing the yield in the culture process to produce cells used as initial raw materials at high density within a limited culture medium.

main sema bg
Development of semaglutide biosimilar

Semaglutide biosimilar

Semaglutide is a diet drug that is effective for a week with a single injection.

It shows a 10~15% weight loss effect when administered consistently, opening a new era in the obesity market.

PEPGENE will provide an easier diet opportunity through semaglutide biosimilar.

main news bg.jpg

Recent News

Check our latest news

​펩진의 뉴스 더보기

All you need is the protein sequence

Excellent CDO service

We provide CDO service for recombinant peptide and protein production based on over 20 years on over 20 years of R&D experience and technology

bottom of page